ARCHIVES

House Bill Provides 5.7% Increase To NIH, But Passage Threatened By Amendments

This article is from The Cancer Letter archive.

Vol. 21 No. 31 | August 4, 1995

Download PDF Visit The Full Archive

Related Articles

QOL With Femara Comparable To Placebo, Analysis Finds

December 26, 2003

Canadian Products Anticancer Drugs In Plant Culture

April 22, 1983

NCI Cooperative Group, Cancer Center Trials Listed

September 26, 2008

MD Anderson’s Balance Sheet is Issue No. 1 For DePinho’s “Moon Shots Program”

October 12, 2012

Senators Urge Grassroots Support For Health Research Fund Legislation

May 16, 1997

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

December 15, 2000